Incidence and prevalence of idiopathic pulmonary fibrosisRAGHU, Ganesh; WEYCKER, Derek; EDELSBERG, John et al.American journal of respiratory and critical care medicine. 2006, Vol 174, Num 7, pp 810-816, issn 1073-449X, 7 p.Article

All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis: Implications for the Design and Execution of Clinical TrialsKING, Talmadge E; ALBERA, Carlo; BRADFORD, Williamson Z et al.American journal of respiratory and critical care medicine. 2014, Vol 189, Num 7, pp 825-831, issn 1073-449X, 7 p.Article

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisKING, Talmadge E; BRADFORD, Williamson Z; LEDERER, David J et al.The New England journal of medicine. 2014, Vol 370, Num 22, pp 2083-2092, issn 0028-4793, 10 p.Article

6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisDU BOIS, Roland M; ALBERA, Carlo; BRADFORD, Williamson Z et al.The European respiratory journal. 2014, Vol 43, Num 5, pp 1421-1429, issn 0903-1936, 9 p.Article

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary FibrosisDU BOIS, Roland M; WEYCKER, Derek; SZWARCBERG, Javier et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 4, pp 459-466, issn 1073-449X, 8 p.Article

High-resolution computed tomography in idiopathic pulmonary fibrosis : Diagnosis and prognosisLYNCH, David A; GODWIN, J. David; WEBB, W. Richard et al.American journal of respiratory and critical care medicine. 2005, Vol 172, Num 4, pp 488-493, issn 1073-449X, 6 p.Article

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in BotswanaTAPPERO, Jordan W; BRADFORD, Williamson Z; MOFFAT, Howard J et al.Clinical infectious diseases. 2005, Vol 41, Num 4, pp 461-469, issn 1058-4838, 9 p.Article

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsNOBLE, Paul W; ALBERA, Carlo; VALEYRE, Dominique et al.Lancet (British edition). 2011, Vol 377, Num 9779, pp 1760-1769, issn 0140-6736, 10 p.Article

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceDU BOIS, Roland M; WEYCKER, Derek; THOMEER, Michiel et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 12, pp 1382-1389, issn 1073-449X, 8 p.Article

Case-Control Study of Shigellosis in San Francisco : The Role of Sexual Transmission and HIV Infection. CommentaryARAGON, Tomas J; VUGIA, Duc J; SHALLOW, Sue et al.Clinical infectious diseases. 2007, Vol 44, Num 3, pp 327-337, issn 1058-4838, 11 p.Article

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialKING, Talmadge E; ALBERA, Carlo; VALEYRE, Dominique et al.Lancet (British edition). 2009, Vol 374, Num 9685, pp 222-228, issn 0140-6736, 7 p.Article

The clinical course of patients with idiopathic pulmonary fibrosisMARTINEZ, Fernando J; SAFRIN, Sharon; BROWN, Kevin K et al.Annals of internal medicine. 2005, Vol 142, Num 12, pp 963-967, issn 0003-4819, 5 p., 1Article

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosisRAGHU, Ganesh; BROWN, Kevin K; BRADFORD, Williamson Z et al.The New England journal of medicine. 2004, Vol 350, Num 2, pp 125-133, issn 0028-4793, 9 p.Article

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantationSONIS, Stephen T; OSTER, Gerry; MILLER, Carole et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2201-2205, issn 0732-183XArticle